Ligand Pharmaceuticals
LGND
#2743
Rank
NZ$11.21 B
Marketcap
NZ$559.44
Share price
2.42%
Change (1 day)
196.86%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): NZ$0.27 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.26 Billion. , an increase over its 2024 earnings that were of NZ$9.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.28 B2848.57%
2024 NZ$9.71 M-91.37%
2023 NZ$0.11 B-7.59%
2022 NZ$0.12 B4%
2021 NZ$0.11 B296.42%
2020 NZ$29.55 M-97.97%
2019 NZ$1.45 B275.62%
2018 NZ$0.38 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$77.12 M55.41%
2015 NZ$49.62 M36.87%
2014 NZ$36.25 M29.59%
2013 NZ$27.97 M1309.35%
2012 NZ$1.98 M-43.97%
2011 NZ$3.54 M-113.19%
2010 -NZ$26.87 Million59.86%
2009 -NZ$16.81 Million-61.33%
2008 -NZ$43.46 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$87.42 Million81.27%
2005 -NZ$48.23 Million
2003 -NZ$33.58 Million-20.6%
2002 -NZ$42.29 Million4.38%
2001 -NZ$40.51 Million-48.83%
2000 -NZ$79.16 Million-19.74%
1999 -NZ$98.63 Million-19.06%
1998 -NZ$0.13 Billion126.71%
1997 -NZ$53.75 Million-5.83%
1996 -NZ$57.08 Million136.23%
1995 -NZ$24.16 Million-33.97%
1994 -NZ$36.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.48 B 15,772.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.54 B 6,370.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.49 B 18,916.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.90 B 5,451.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.89 Billion-410.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$23.02 B 7,935.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.80 B 5,763.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.52 B 6,016.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA